There is currently a disruption in the supply EpiPen® and EpiPen Junior® adrenaline auto-injectors (AAIs). Supplies are now critical and NHS England are implementing controls on the supply of 150 microgram AAI’s. This means restricting the issue of new devices until further notice, and as a result some patients may only receive one device even if two have been prescribed.
Pharmacies and dispensing practices have received advice on this from NHS England. In this situation patients may present for an additional prescription which can be dispensed at a later date once the supply situation has eased. Please see the guidance developed especially for pharmacies and dispensing GPs, for when a patient asks for a 150mcg adrenaline auto injector. There is also an accompanying Q&A.
740